News

DermaXon: Missoula startup receives $99K grant from the Montana Department of Commerce to research med for chronic pain

Missoula upstart biotech company DermaXon http://dermaxon.com/ received a grant from the Montana Department of Commerce last month to help fund more studies and generate data needed to attract investors for a new compound to treat chronic neuropathic pain.

The $99,326 grant from the Montana Board of Research and Commercialization Technology http://marketmt.com/MBRCT , or MBRCT, will help finance further research and development of the topical treatment. Data generated by the research will help attract investors and grants from the government.

DermaXon founders Fanny Astruc-Diaz and Philippe Diaz can then begin clinical trials for the medication to gain approval by the FDA, allowing sales nationwide.

By Mari Hall

https://www.missoulacurrent.com/business/2018/08/dermaxon-grant-pain-medication/

Posted in:

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.